Krystal Biotech (KRYS) Earnings Date, Estimates & Call Transcripts → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free KRYS Stock Alerts $164.42 -1.26 (-0.76%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 5EstimatedActual EPS (May. 6) $0.03 Missed By -$0.17 Consensus EPS (May. 6) $0.20 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Krystal Biotech Earnings AlertsEnter your email address below to receive the latest news and earnings results for KRYS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKRYS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KRYS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. Krystal Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242$0.08$0.30$0.19Q2 20242$0.37$0.49$0.43Q3 20242$0.31$0.63$0.47Q4 20242$0.18$0.75$0.47FY 20248$0.94$2.17$1.56Q1 20251$1.41$1.41$1.41Q2 20251$1.27$1.27$1.27Q3 20251$1.61$1.61$1.61Q4 20251$1.28$1.28$1.28FY 20254$5.57$5.57$5.57KRYS Earnings Date and InformationKrystal Biotech last released its quarterly earnings results on May 6th, 2024. The reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.20 by $0.17. The firm earned $45.25 million during the quarter, compared to the consensus estimate of $47.37 million. Its revenue for the quarter was up 452400.0% on a year-over-year basis. Krystal Biotech has generated $1.87 earnings per share over the last year ($1.87 diluted earnings per share) and currently has a price-to-earnings ratio of 87.9. Earnings for Krystal Biotech are expected to grow by 110.19% in the coming year, from $2.06 to $4.33 per share. Krystal Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.Read More Krystal Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/5/2024(Estimated)------- 5/6/2024Q1 2024$0.20$0.03($0.17)$0.03$47.37 million$45.25 million 2/26/2024Q4 2023($0.52)$0.30+$0.82$0.30$27.43 million$42.14 million 11/6/2023Q3 2023($1.10)$2.79+$3.89($4.13)$6.29 million$8.60 million 8/7/2023Q2 2023($1.27)($1.25)+$0.02($1.25)--5/8/2023Q1 2023($1.41)($1.76)($0.35)($1.76)--2/27/2023Q4 2022($1.26)($1.25)+$0.01($1.25)-- Get the Latest News and Ratings for KRYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Q3 2022($1.23)($1.17)+$0.06($1.17)--8/8/2022Q2 2022($1.08)($1.10)($0.02)($1.10)--5/9/2022Q1 2022($0.96)($0.99)($0.03)$0.01--2/28/2022Q4 2021($0.76)($0.94)($0.18)($0.94)-- 11/7/2021Q3 2021($0.76)($0.70)+$0.06($0.70)--8/8/2021Q2 2021($0.76)($0.74)+$0.02($0.74)--5/9/2021Q1 2021($0.62)($0.74)($0.12)($0.74)-- 2/28/2021Q4 2020($0.61)($0.53)+$0.08($0.53)--11/14/2020Q3 2020($0.47)($0.49)($0.02)($0.49)-- 8/10/2020Q2 2020($0.4540)($0.37)+$0.0840($0.37)--5/4/2020Q1 2020($0.44)($0.31)+$0.13($0.31)--3/10/2020Q4($0.3290)($0.31)+$0.0190($0.31)--11/4/2019Q3 2019($0.3870)($0.25)+$0.1370($0.25)--8/5/2019Q2 2019($0.32)($0.37)($0.05)($0.37)-- Krystal Biotech Earnings - Frequently Asked Questions When is Krystal Biotech's earnings date? Krystal Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on KRYS's earnings history. Did Krystal Biotech beat their earnings estimates last quarter? In the previous quarter, Krystal Biotech (NASDAQ:KRYS) missed the analysts' consensus estimate of $0.20 by $0.17 with a reported earnings per share (EPS) of $0.03. Learn more on analysts' earnings estimate vs. KRYS's actual earnings. How can I listen to Krystal Biotech's earnings conference call? The conference call for Krystal Biotech's latest earnings report can be listened to online. Listen to Conference Call How can I read Krystal Biotech's conference call transcript? The conference call transcript for Krystal Biotech's latest earnings report can be read online. Read Transcript How can I view Krystal Biotech's earnings report? Krystal Biotech's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Krystal Biotech generate each year? Krystal Biotech (NASDAQ:KRYS) has a recorded annual revenue of $50.70 million. How much profit does Krystal Biotech generate each year? Krystal Biotech (NASDAQ:KRYS) has a recorded net income of $10.93 million. KRYS has generated $1.87 earnings per share over the last four quarters. What is Krystal Biotech's price-to-earnings ratio? Krystal Biotech (NASDAQ:KRYS) has a trailing price-to-earnings ratio of 87.93 and a forward price-to-earnings ratio of 79.82. What is Krystal Biotech's EPS forecast for next year? Krystal Biotech's earnings are expected to grow from $2.06 per share to $4.33 per share in the next year, which is a 110.19% increase. More Earnings Resources from MarketBeat Related Companies: TSHA Earnings ITOS Earnings ALEC Earnings PRQR Earnings VXRT Earnings PASG Earnings NBIX Earnings TECH Earnings QGEN Earnings RGEN Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:KRYS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.